Chapter Six
Administrative Law
A Manager’s Dilemma: Putting It into Practice
Getting into Bed with the Regulators
Issue Presented: Are there any legal or ethical barriers to relationships between corporate
officers and members of administrative agencies involved in reviewing or regulating
corporate activity?
This question is ethical and practical, not legal, at least from Dora Reilly’s point of view.
From a legal perspective, she is free to date whomever she pleases, although providing sexual
favors in exchange for favorable treatment by the FDA would constitute bribery, and thus
Questions and Case Problems
Question 1
Issue Presented: Is a statute giving the Department of the Interior the power to allow or
curtail mining within the national forests “as the best interests of all users of the national
forest shall dictate” a valid delegation of legislative power?
A legislative delegation of power to an administrative agency is valid as long as
Congress provides an “intelligible principleto guide the exercise of the delegated discretion.
Panama Refining and Schechter seem to embody the exceptions rather than the rule
concerning a proper delegation of authority. Indeed, the Supreme Court has not struck down a
delegation of legislative authority since 1935. In the decades since these cases were decided, the
Court has upheld vague standards, such as those requiring rules to be set “in the public
interest,” “for the public convenience, interest or necessity,” to be “reasonably fair,” or “to
prevent unfair methods of competition. Despite the Court’s relaxed standards, however,
Congress still does not have the ability to delegate “unbridled discretion” to administrative
agencies.
Question 2
Issue Presented: What arguments can Ethyl advance to persuade the court to strike down the
EPA’s regulations? How else might Ethyl affect the EPA’s rulemaking?
In Ethyl Corp v. EPA, 306 F.3d 1144 (D.C. Cir. 2002), Ethyl Corporation argued that the
CAP 2000 regulation promulgated by the EPA violated the Clean Air Act because it provided
for test procedures and methods to be vetted in individual closed proceedings rather than in a
notice-and-comment rulemaking. Ethyl Corporation claimed that the mechanism adopted by
The D.C. Circuit concluded that the requirements of injury were satisfied and fairly
traceable to the CAP 2000 regulation and that the injury was redressable. On the question of
injury, the court wrote: “CAP 2000’s provision for closed-door adoption of emission test
procedures deprives Ethyl of information that might well help it develop and improve its
products with an eye to conformity to emissions needs.”
The court’s opinion illuminates how Ethyl could have affected the EPA’s
rulemaking:
[I]t is true . . . that an open procedurethe very thing mandated by Congressis
less convenient than a closed one. It may be. Other parties may raise questions or
find fault in procedures that look fine to the agency and the auto makers. But
Question 3
Issue Presented: What is the appropriate standard for reviewing the FDA’s determination not
to imply an exemption from the Federal Food, Drug, and Cosmetic Act for terminally ill
cancer patients?
The appropriate standard of review for administrative interpretations of statutory
language is one of substantial deference, particularly when an agency’s interpretation involves
issues of public concern. See United States v. Rutherford, 442 U.S. 544 (1979).
Once the court has satisfied itself that the statute is “plain and unambiguous,” it will be
highly deferential to an administrative interpretation in accord with the statute’s plain meaning.
Only if the agency’s interpretation gives rise to an absurd result will the court imply an
exception to the statute. Underlying this result is a belief that if Congress has not seen fit to
correct any misperceptions that might arise from the plain meaning of a statute it has enacted
(and if administrative agencies act in accordance with the language, history, and purpose of the
statute), it would be inappropriate for the U.S. Supreme Court to rewrite the statute.
The principal medical justification for this kind of paternalism is that it is often difficult
to tell, except in retrospect, whether conventional therapy will prove effective. However,
doctors can say, with reasonable certainty, that if a cancer patient rejects conventional therapy
in favor of a drug with no demonstrable curable properties, the result is almost certain to be
death. Largely for this reason, the Supreme Court accepted the FDA’s interpretation that even
the terminally ill need to be protected against potentially hazardous drugs.
Question 4
Issue Presented: Was it violation of the constitutional requirement of separation of powers
for Congress to delegate to the Comptroller the duty to calculate budget reductions?
In Bowsher v. Synar, 478 U.S. 714 (1986), the U.S. Supreme Court ruled that the Graham-
Question 5
Issue Presented: Would the U.S. Supreme Court allow warrantless administrative inspections
to occur in the following industries: (a) firearms, (b) mining, (c) pharmaceutical, and (d)
computer software?
As a general matter, the reach of the Fourth Amendment in the administrative law
context depends on the specific enforcement needs and privacy guarantees of the particular
statutes governing the agencies. There is no blanket rule either prohibiting or endorsing
warrantless searches in administrative agency investigations. An exception to the warrant
requirement has been recognized for “closely regulatedindustries, but the exception does not
apply simply because a business is engaged in interstate commerce.
When Congress explicitly exempts federal agencies from the warrant requirement, such
an exemption is presumptively valid. However, Congress’s power to exempt agencies from the
Fourth Amendment is not absolute. Under current Supreme Court doctrine, an explicit
exemption from the Fourth Amendment is only permissible in “pervasively regulated” or
particularly hazardous industries.
Question 6
Issue Presented: Did the SEC exceed its rulemaking authority by adopting Rule 14e-3(a)
without requiring a showing that the trading at issue entailed a breach of fiduciary duty?
In United States v. O’Hagan, 521 U.S. 642 (1997), the Supreme Court held that Rule 14e
3(a) was a proper exercise of the SEC’s prophylactic power under Section 14(e) to “prescribe
means reasonably designed to prevent” fraudulent acts. The Court found it unnecessary to
determine whether the SEC’s “defining power” under Section 14(e) was broader than its fraud
Question 7
Issue Presented: What determines whether a party has standing under Section 7(a)(2) of the
Endangered Species Act of 1973?
In Lujan v. Defenders of Wildlife, 504 U.S. 555 (1992), the U.S. Supreme Court ruled that
Kelly and Skilbred did not assert sufficiently imminent injury to have standing and that their
claimed injury was not redressable. Regarding the determination of standing, the Supreme
Court explained:
Over the years, our cases have established that the irreducible constitutional
minimum of standing contains three elements. First, the plaintiff must have
suffered an “injury in fact”—an invasion of a legally protected interest which is
(a) concrete and particularized, and (b) “actual or imminent, not ‘conjectural’ or
‘hypothetical.’” Second, there must be a causal connection between the injury
and the conduct complained of—the injury has to be “fairly . . . trace[able] to the
Mses. Kelly and Skilbred. That the women “had visited” the areas of the projects
before the projects commenced proves nothing. As we have said in a related
context, “Past exposure to illegal conduct does not in itself show a present case or
controversy regarding injunctive relief . . . if unaccompanied by any continuing,
present adverse effects.” And the affiants’ profession of an “intent” to return to
the places they had visited beforewhere they will presumably, this time, be
deprived of the opportunity to observe animals of the endangered speciesis
simply not enough. Such “some day” intentions—without any description of
concrete plans, or indeed even any specification of when the some day will be
do not support a finding of the “actual or imminent” injury that our cases
require.
In Bennett v. Spear, 520 U.S. 154 (1997), the plaintiffs made the following claims about the
Fish and Wildlife regulation:
That (1) the lake-level restrictions (a) would adversely affect the plaintiffs’ use of
water from the project, and (b) were not necessary to protect the fish; (2) the
defendants, by issuing a biological opinion which made unsubstantiated findings
as to the necessity of the restrictions, had violated 7 of the Endangered Species
interests did not fall within the zone of interests sought to be protected by ESA.”
The U.S. Court of Appeals affirmed, then the U.S. Supreme Court reversed and
held that the plaintiffs did have standing:
The first question in the present case is whether the ESA’s citizensuit provision .
. . negates the zone-of-interests test (or, perhaps more accurately, expands the
Given petitioners’ allegation that the amount of available water will be reduced
and that they will be adversely affected thereby, it is easy to presume specific
facts under which petitioners will be injuredfor example, the Bureau’s
distribution of the reduction pro rata among its customers. The complaint alleges
the requisite injury in fact.
The Government also contests compliance with the second and third Article III
standing requirements, contending that any injury suffered by petitioners is
neither “fairly traceable” to the Service’s Biological Opinion, nor “redressable” by
a favorable judicial ruling, because the “action agency” (the Bureau) retains
Given all of this, and given petitioners’ allegation that the Bureau had, until
issuance of the Biological Opinion, operated the Klamath Project in the same
manner throughout the twentieth century, it is not difficult to conclude that
petitioners have met their burdenwhich is relatively modest at this stage of the
Question 8
Issue Presented: Is a rule promulgated by the SEC excluding fixed indexed annuities (FIA)
from the definition of “annuity contract” within the meaning of the Securities Act valid?
In American Equity Investment Life Insurance Co. v. SEC, 613 F.3d 166 (D.C. Cir. 2010), the
D.C. Circuit held that Rule 151A was invalid.
The insurance companies first argued that the SEC erred in excluding FIAs from the
definition of “annuity contract” under Section3(a)(8) of the Securities Act. Specifically, they
Under Chevron’s first step, the court must determine whether the statute being
interpreted is ambiguous. If the court determines that the statute is either “silent or ambiguous”
with respect to the issue at hand, the first Chevron step is satisfied. In the present case, the court
determined that the Act was ambiguous, or at least silent, on whether the term “annuity
contract” encompassed all forms of contracts that may be described as annuities. Thus, the first
step was satisfied.
Under Chevron’s second step, the court must determine whether the agency’s rule is a
“reasonable” interpretation of the statute. The insurance companies argued that the SEC, in
The insurance companies next argued that the SEC failed to balance the investment risks
assumed by the insurer against those assumed by the purchaser in determining whether an FIA
was an annuity or a security. The court rejected this argument, finding that the SEC had in fact
weighed the investment risks. The SEC noted that annuities include “investment risktaking” by
the insurer, with minimal risk exposure to the purchaser. FIAs, on the other hand, left a more
than minimal risk upon the purchaser.
The insurance companies further argued that Rule 151A conflicts with Rule 151, which
states that annuity contracts that have interest rates tied to a securities index fall under Section
Although the court determined that the SEC’s interpretation of the statute was valid
under Chevron, the insurance companies further argued that the SEC failed to undertake
properly its statutory responsibility under the Securities Act to consider Rule 151A’s effect on
efficiency, competition, and capital formation. Under the Administrative Procedure Act, a court
must set aside agency action that is “arbitrary, capricious, an abuse of discretion, or otherwise
not in accordance with law.”
The SEC argued that Rule 151A would enhance competition by providing greater clarity
to an area of law that was unclear and would improve efficiency by requiring fuller disclosure
to investors. The court rejected SEC’s claims as overly broad. The court explained that the
This case has important implications for future agency action, because it requires
a more explicit finding of a rule’s “effect on efficiency, competition, and capital information”
than was mandated in earlier cases.